Cite
HARVARD Citation
Exman, P. et al. (2018). Abemaciclib for the treatment of HR+/HER2- breast cancer. Expert review of precision medicine and drug development. 3 (3), pp. 151-161. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Exman, P. et al. (2018). Abemaciclib for the treatment of HR+/HER2- breast cancer. Expert review of precision medicine and drug development. 3 (3), pp. 151-161. [Online].